Commonwealth Equity Services’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$135K Buy
+10,136
New +$147K ﹤0.01% 4173
2025
Q3
– Sell
-11,066
Closed -$156K – 4246
2025
Q2
$156K Sell
11,066
-2,086
-16% -$37.2K ﹤0.01% 3983
2025
Q1
$316K Sell
13,152
-452
-3% -$15.9K ﹤0.01% 3446
2024
Q4
$508K Buy
13,604
+189
+1% +$8.82K ﹤0.01% 2932
2024
Q3
$670K Buy
13,415
+77
+0.6% +$3K ﹤0.01% 2661
2024
Q2
$463K Buy
13,338
+1,150
+9% +$45.5K ﹤0.01% 2898
2024
Q1
$667K Buy
12,188
+830
+7% +$41.1K ﹤0.01% 2572
2023
Q4
$486K Buy
11,358
+2,474
+28% +$76.9K ﹤0.01% 2734
2023
Q3
$231K Sell
8,884
-13
-0.1% -$270 ﹤0.01% 3257
2023
Q2
$213K Buy
+8,897
New +$153K ﹤0.01% 3351

Other funds holding BHVN

Commonwealth Equity Services's BHVN Position: Q3 2026 in Review

Commonwealth Equity Services opened a new position in Biohaven (BHVN) in Q3 2026: 10,136 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #4173 among its holdings. This is a return to the name: Commonwealth Equity Services previously reported a position in BHVN as recently as Q2 2025.

Commonwealth Equity Services first reported a position in BHVN in Q2 2023 and has held it in 10 quarters since. The position peaked at $670K in Q3 2024. 108 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • Commonwealth Equity Services held 10,136 shares of Biohaven worth $135K as of Q3 2026.
  • Biohaven was a new Commonwealth Equity Services position in Q3 2026.
  • Biohaven made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #4173 holding.
  • Commonwealth Equity Services first reported a position in Biohaven in Q2 2023 and has held it in 10 quarters since.
  • Commonwealth Equity Services's Biohaven position peaked at $670K in Q3 2024.
  • 108 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.